Literature DB >> 23481105

Neonatal herpes simplex virus infections.

Swetha G Pinninti1, David W Kimberlin.   

Abstract

Neonatal herpes simplex virus infections are uncommon, but because of the morbidity and mortality associated with the infection they are often considered in the differential diagnosis of ill neonates. The use of polymerase chain reaction for diagnosis of central nervous system infections and the development of safe and effective antiviral therapy has revolutionized the diagnosis and management of these infants. Initiation of long-term antiviral suppressive therapy in these infants has led to significant improvement in morbidity. This article summarizes the epidemiology of neonatal herpes simplex virus infections and discusses clinical presentation, diagnosis, management, and follow up of infants with neonatal herpes disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23481105     DOI: 10.1016/j.pcl.2012.12.005

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  17 in total

1.  Evaluation for Neonatal HSV in Infants Undergoing Workup for Serious Bacterial Infection: A 5-Year Retrospective Review.

Authors:  Laura H Brower; Paria M Wilson; Eileen Murtagh-Kurowski; Joshua D Courter; Samir S Shah; Amanda C Schondelmeyer
Journal:  Hosp Pediatr       Date:  2020-05-08

2.  Herpes simplex ophthalmia neonatorum: a sight-threatening diagnosis.

Authors:  Nimra Maqsood; Usman Mahmood
Journal:  Br J Gen Pract       Date:  2020-10-01       Impact factor: 5.386

3.  Herpes Simplex Virus Infection in Infants Undergoing Meningitis Evaluation.

Authors:  Andrea T Cruz; Stephen B Freedman; Dina M Kulik; Pamela J Okada; Alesia H Fleming; Rakesh D Mistry; Joanna E Thomson; David Schnadower; Joseph L Arms; Prashant Mahajan; Aris C Garro; Christopher M Pruitt; Fran Balamuth; Neil G Uspal; Paul L Aronson; Todd W Lyons; Amy D Thompson; Sarah J Curtis; Paul T Ishimine; Suzanne M Schmidt; Stuart A Bradin; Kendra L Grether-Jones; Aaron S Miller; Jeffrey Louie; Samir S Shah; Lise E Nigrovic
Journal:  Pediatrics       Date:  2018-01-03       Impact factor: 7.124

Review 4.  Early-onset neonatal sepsis.

Authors:  Kari A Simonsen; Ann L Anderson-Berry; Shirley F Delair; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

5.  HSV targeting of the host phosphatase PP1α is required for disseminated disease in the neonate and contributes to pathogenesis in the brain.

Authors:  Douglas R Wilcox; William J Muller; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

6.  Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D.

Authors:  J Charles Whitbeck; Zhen-Yu Huang; Tina M Cairns; John R Gallagher; Huan Lou; Manuel Ponce-de-Leon; Robert B Belshe; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

Review 7.  Infections and Pregnancy: Effects on Maternal and Child Health.

Authors:  Manoj Kumar; Marwa Saadaoui; Souhaila Al Khodor
Journal:  Front Cell Infect Microbiol       Date:  2022-06-08       Impact factor: 6.073

Review 8.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

9.  Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections.

Authors:  Jessica E Ericson; Martyn Gostelow; Julie Autmizguine; Christoph P Hornik; Reese H Clark; Daniel K Benjamin; P Brian Smith
Journal:  Pediatr Infect Dis J       Date:  2017-04       Impact factor: 3.806

Review 10.  Prevention and treatment of neonatal herpes simplex virus infection.

Authors:  Nicole L Samies; Scott H James
Journal:  Antiviral Res       Date:  2020-02-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.